EPMA Journal is a journal of predictive, preventive and personalized medicine (PPPM). The journal provides expert viewpoints and research on medical innovations and advanced healthcare using predictive diagnostics, targeted preventive measures and personalized patient treatments. The journal is indexed by PubMed, Embase and Scopus.

  • The only journal in the field of predictive, preventive and personalized medicine (PPPM)
  • High visibility for your research
  • Official journal of the European Association for Predictive, Preventive & Personalised Medicine

Journal information

Editor-in-Chief
  • Olga Golubnitschaja
Publishing model
Hybrid. Open Access options available

Journal metrics

4.901 (2019)
Impact factor
21 days
Submission to first decision
89 days
Submission to acceptance
124,537 (2019)
Downloads

Latest issue

Volume 11

Issue 2, June 2020

Predictive, Preventive and Personalised Strategies in Combatting COVID-19 Pandemic and Non-Communicable Disorders

Latest articles

Journal updates

  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

  • Featured article: Targeting the endocannabinoid system

    Cannabis-inspired medical products are garnering increasing attention from the scientific community, general public, and health policy makers. A plethora of scientific literature demonstrates intricate engagement of the endocannabinoid system with human immunology, psychology, developmental processes, neuronal plasticity, signal transduction, and metabolic regulation. Despite the therapeutic potential, the adverse psychoactive effects and historical stigma, cannabinoids have limited widespread clinical application. 


    In this review, Reddy et al outline of the endocannabinoid system and provide an in-depth discussion of the therapeutic interventions by endocannabinoids in various neurological disorders.

  • Meet our Editor-in-Chief, Professor Dr. Olga Golubnitschaja

    Dr. Golubnitschaja is the head of the world's first Predictive, Preventive and Personalised (3P) Medicine unit at the Department of Radiation Oncology, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany. 

    Olga Golubnitschaja
View all updates

About this journal

Electronic ISSN
1878-5085
Print ISSN
1878-5077
Abstracted and indexed in
  1. CAB Abstracts
  2. CNKI
  3. Dimensions
  4. EBSCO Discovery Service
  5. EMBASE
  6. Gale
  7. Google Scholar
  8. Institute of Scientific and Technical Information of China
  9. Japanese Science and Technology Agency (JST)
  10. Journal Citation Reports/Science Edition
  11. Meta
  12. Naver
  13. OCLC WorldCat Discovery Service
  14. ProQuest Central
  15. ProQuest Health & Medical Collection
  16. ProQuest Health Research Premium Collection
  17. ProQuest-ExLibris Primo
  18. ProQuest-ExLibris Summon
  19. PubMedCentral
  20. Reaxys
  21. SCImago
  22. SCOPUS
  23. Science Citation Index Expanded (SciSearch)
  24. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© European Association for Predictive, Preventive and Personalised Medicine (EPMA)